Home2025-06-26T15:58:31+02:00

InnovaTivE in situ 4D biopriNTing for regenerAtion of CoLorEctal mucosa and submucosa

InnovaTivE in situ 4D biopriNTing for regenerAtion of CoLorEctal mucosa and submucosa

PROJECt

TENTACLE pioneers in-situ 4D bioprinting to advance minimally invasive surgery, reducing patient trauma and improving care

Strategy

The project aims to offer a less invasive alternative for treating colorectal diseases by integrating 4D bioprinting into endoscopic procedures

RESULTS

Discover how TENTACLE’s innovative approach is shaping the future of precision medicine and redefining surgical standards

*

Duration

48 months

*

Partners

10

*

EU Contribution

7.555.750,00

About the project

TENTACLE pioneers a radically new way to treat colorectal diseases thanks to an innovative bioprinting strategy, marking a new chapter in regenerative medicine thanks to a cutting-edge use of biomedical engineering.

Latest News & Events

more news

FORTHCOMING EVENTS

No upcoming events…

Latest news

*our TEAM

The excellence in their respective fields of expertise and their complementarity has been the underlying principle used to build TENTACLE consortium.

The consortium involves 10 partners including 5 topquality academic institutions.

*Contact us

Juergen Groll Tentacle Project Coordinator
PROJECT COORDINATOR

Jürgen Groll

SCIENTIFIC COORDINATOR

Giovanni Vozzi

Isella-Vicini---Tentacle---Dissemination-Manager
PROJECT MANAGER & DISSEMINATION MANAGER

Isella Vicini

PROJECT DETAILS

Project number: 101191747
Project name: InnovaTivE in situ 4D biopriNTing for regenerAtion of CoLorEctal mucosa and submucosa
Project acronym: TENTACLE
Topic: HORIZON-HLTH-2024-TOOL-11-02
Granting authority: HADEA
Project starting date: 01 January 2025
Project duration: 48 months
EU Contribution: 7.555.750,00 Euro

“Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.”
GA.101191747

Go to Top